| Literature DB >> 28304365 |
Wenyi Liang1, Wenjing Chen2, Lingfang Wu3, Shi Li4, Qi Qi5, Yaping Cui6, Linjin Liang7, Ting Ye8, Lanzhen Zhang9.
Abstract
Danshen, the dried root of Salvia miltiorrhiza Bge., is a widely used commercially available herbal drug, and unstable quality of different samples is a current issue. This study focused on a comprehensive and systematic method combining fingerprints and chemical identification with chemometrics for discrimination and quality assessment of Danshen samples. Twenty-five samples were analyzed by HPLC-PAD and HPLC-MSn. Forty-nine components were identified and characteristic fragmentation regularities were summarized for further interpretation of bioactive components. Chemometric analysis was employed to differentiate samples and clarify the quality differences of Danshen including hierarchical cluster analysis, principal component analysis, and partial least squares discriminant analysis. Consistent results were that the samples were divided into three categories which reflected the difference in quality of Danshen samples. By analyzing the reasons for sample classification, it was revealed that the processing method had a more obvious impact on sample classification than the geographical origin, it induced the different content of bioactive compounds and finally lead to different qualities. Cryptotanshinone, trijuganone B, and 15,16-dihydrotanshinone I were screened out as markers to distinguish samples by different processing methods. The developed strategy could provide a reference for evaluation and discrimination of other traditional herbal medicines.Entities:
Keywords: HPLC-MSn; Salvia miltiorrhiza; chemical marker; chemometric; fingerprint; quality evaluation
Mesh:
Substances:
Year: 2017 PMID: 28304365 PMCID: PMC6155183 DOI: 10.3390/molecules22030478
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1HPLC fingerprints of different Danshen samples. Peak numbers are based on Table 2.
Information summary and similarity values of tested samples.
| No. | Origins | Similarities | No. | Origins | Similarites |
|---|---|---|---|---|---|
| S1 | Shandong | 0.972 | S14 | Shanxi | 0.982 |
| S2 | Shandong | 0.997 | S15 | Shanxi | 0.994 |
| S3 | Shandong | 0.993 | S16 | Sichuan | 0.997 |
| S4 | Shandong | 0.999 | S17 | Sichuan | 0.991 |
| S5 | Shaanxi | 0.998 | S18 | Sichuan | 0.999 |
| S6 | Shaanxi | 0.999 | S19 | Jiangsu | 0.996 |
| S7 | Shaanxi | 0.997 | S20 | Jiangsu | 0.973 |
| S8 | Henan | 0.999 | S21 | Gansu | 0.997 |
| S9 | Henan | 0.943 | S22 | Hunan | 0.998 |
| S10 | Hebei | 0.999 | S23 | Hunan | 0.999 |
| S11 | Hebei | 0.999 | S24 | Yunnan | 0.998 |
| S12 | Hebei | 0.998 | S25 | Anhui | 0.994 |
| S13 | Shanxi | 0.975 |
Identification of compounds in Danshen by HPLC-MSn.
| ID | Mass Ion ( | Data-Dependent MSn Data ( | Identification | |
|---|---|---|---|---|
| 1 a | 4.79 | [M − H]⁻ 197.0452 | MS2:178.9395 MS3: 134.9681, 106.9022 | Danshensu |
| 2 | 6.19 | [M − H]⁻ 153.0191 | MS2: 109.0295 | Protocatechuic acid |
| 3 | 7.98 | [M − H]⁻ 341.1076 | MS2:178.9334, 160.8835, 112.8926 | 1- |
| 4 a | 8.96 | [M − H]⁻ 137.0242 | MS2: 109.0310 | Protocatechuic aldehyde |
| 5 | 13.43 | [M − H]⁻ 179.0344 | MS2: 135.0451 | Caffeic acid |
| 6 | 15.10 | [M − H]⁻ 683.1226 | MS2: 665.2238, 621.3198, 441.1573 | 3,4-Dihydroxy-(1α,3α,4α,5β)-1-carboxy-4-hydroxy-1,3,5-cyclohexanetriyl ester-benzenepropanoic acid |
| 7 | 15.74 | [M − H]⁻ 313.0707 | MS2: 269.0386, 158.9700, 108.8062 | Salvianolic acid F |
| 8 | 17.97 | [M − H]⁻ 539.1178 | MS2: 521.1625, 495.3337, 359.1708, 341.1323, 297.1190 | Yunnaneic acid D/isomer |
| 9 | 19.34 | [M − H]⁻ 521.1287 | MS2: 498.5744, 477.9366, 359.1708, 341.1323, 297.1190 | Salviaflaside |
| 10 | 22.09 | [M − H]⁻ 339.0501 | MS2: 320.9998, 294.9889, 184.9634 | Salvianolic acid G |
| 11 | 22.76 | [M − H]⁻ 735.1541 | MS2: 716.9385, 537.1756, 519.1987, 555.0787 | Hydrosalvianolic acid B |
| 12 | 25.17 | [M − H]⁻ 717.1436 | MS2: 693.3942, 519.1561, 321.0740, 537.1210 | Iso salvianolic acid E |
| 13 a | 26.43 | [M − H]⁻ 359.0763 | MS2: 341.1426, 160.8524, 197.0617, 178.8373 | Rosmarinic acid |
| 14 | 28.12 | [M − H]⁻ 537.1038 | MS2: 493.1133, 313.0726, 295.0606 | Lithospermic acid |
| 15 | 28.51 | [M − H]⁻ 749.1708 | MS2: 717.2390, 551.2418, 321.1771 | 8-Hydroxy-9''-methyl-salvianolate B |
| 16 a | 32.67 | [M − H]⁻ 717.1426 | MS2: 519.1459, 321.1666 | Salvianolic acid B |
| 17 | 33.94 | [M − H]⁻ 717.1445 | MS2: 519.1002, 321.1299 | Iso salvianolic acid B |
| 18 | 37.06 | [M − H]⁻ 717.1447 | MS2: 673.0787, 519.1280, 321.0964 | Salvianolic acid L |
| 19 | 38.03 | [M − H]⁻ 493.1127 | MS2: 475.0607, 313.1490, 295.0408 | Salvianolic acid A |
| 20 | 39.86 | [M − H]⁻ 731.1599 | MS2: 713.0930, 533.1845, 335.1095 | Methyl salvianolic acid B |
| 21 | 40.50 | [M − H]⁻ 551.1185 | MS2: 519.1639, 353.0330, 321.0014 | Methyl salvianolic acid I/H |
| 22 | 45.70 | [M − H]⁻ 717.6401 | MS2: 673.2368, 617.6599, 519.1243, 321.1423 | Salvianolic acid E |
| 23 | 64.63 | [M − H]⁻ 505.1127 | MS2: 473.1639, 321.1718 | Methyl salvianolate C |
| 24 | 21.35 | [M + H]+ 315.1228 | MS2: 297.0677, 266.9693, 249.0071 | 17-Hydroxytanshindiol B |
| 25 | 37.09 | [M + H]+ 313.1072 | MS2: 294.9926, 264.9864, 247.0231 | Tanshinone A |
| 26 | 46.34 | [M + H]+ 297.1122 | MS2: 279.0668, 250.9774, 223.1107 | Tanshinone VI |
| 27 | 47.88 | [M + H]+ 297.1127 | MS2: 279.0222, 269.0689, 251.0355 | Danshenxinkun A |
| 28 | 48.81 | [M + H]+ 299.1283 | MS2: 281.0504, 263.0121 | 15,16-Dihydrotanshinol B |
| 29 | 56.29 | [M + H]+ 313.1437 | MS2: 295.0622, 277.0113, 267.0143 | Tanshindiol B |
| 30 | 60.48 | [M + H]+ 313.1440 | MS2: 295.0879, 277.0540, 267.0566, 249.0650 | Tanshindiol C |
| 31 | 65.82 | [M + H]+ 295.0967 | MS2: 276.9836, 267.0344, 252.9953,249.0193 | 3 |
| 32 | 66.45 | [M + H]+ 297.1124 | MS2: 279.0198, 261.0336 | Tanshinol B |
| 33 | 70.11 | [M + H]+ 295.0966 | MS2: 277.0328, 267.0656 | Trijuganone A |
| 34 | 71.64 | [M + H]+ 311.1276 | MS2: 293.0745, 267.0956MS3: 275.0365, 251.0166 | Tanshinone IIB |
| 35 | 71.86 | [M + H]+ 311.1279 | MS2: 293.0213, 275.0118, 267.0738 | 3 |
| 36 | 74.83 | [M + H]+ 341.1381 | MS2: 281.0114, 263.0162 | Methyldihydronortanshinonate |
| 37 | 78.02 | [M + H]+ 309.1119 | MS2: 281.0635 | Tanshinaldehyde |
| 38 | 78.92 | [M + H]+ 311.1280 | MS2: 293.0916, 283.0533, 267.0832 | 17-Hydroxycryptotanshinone |
| 39 a | 79.33 | [M + H]+ 279.1015 | MS2: 260.9656, 233.0795 | 15,16-Dihydrotanshinone I |
| 40 | 80.23 | [M + H]+ 297.1483 | MS2: 269.1145, 279.0749, 251.1033 | 1-Oxomiltirone |
| 41 | 81.76 | [M + H]+ 281.1177 | MS2: 263.0103, 252.9724, 235.0020 | Trijuganone B |
| 42 | 82.68 | [M + H]+ 339.1228 | MS2: 311.0540, 279.0392, 261.1021 | Methyl tanshinonate |
| 43 | 85.19 | [M + H]+ 267.1381 | MS2: 249.0448, 224.9753 | 4-Methylenemiltirone |
| 44 a | 86.29 | [M + H]+ 297.1481 | MS2: 279.1028, 251.0883, 237.0703 | Cryptotanshinone |
| 45 a | 87.42 | [M + H]+ 277.0855 | MS2: 249.0238, 231.058.9814 | Tanshinone I |
| 46 | 90.41 | [M + H]+ 279.1016 | MS2: 260.9862, 233.0613, 221.0357, 258.9814 | 1,2-Dihydrotanshinone I /3,4-dihydrotanshinone I |
| 47 | 93.18 | [M + H]+ 281.1539 | MS2: 220.9732, 253.0703, 263.1043, 239.0273 | 1,2-Didehydromiltirone |
| 48 a | 95.04 | [M + H]+ 295.1327 | MS2: 277.0313, 249.1205, 235.0146 | Tanshinone IIA |
| 49 | 97.18 | [M + H]+ 283.1689 | MS2: 265.0710, 241.0755, 237.0394, 223.0768 | Miltirone |
a Positively identified via comparison with reference standards.
Figure 2(A) TIC chromatogram in negative mode and (B) TIC chromatogram in positive mode of Danshen. The peak numbers are based on Table 2.
Figure 3The proposed fragmentation pathway of Danshensu.
Figure 4The proposed fragmentation pathway of protocatechuic aldehyde.
Figure 5The proposed fragmentation pathway of rosmarinic acid.
Figure 6The proposed fragmentation pathway of salvianolic acid B.
Figure 7The proposed fragmentation pathway of cryptotanshinone.
Figure 8The proposed fragmentation pathway of tanshinone I.
Figure 9The proposed fragmentation pathway of tanshinone IIA.
Figure 10HCA dendrogram of different Danshen samples.
Figure 113D score plot of PCA on the first three PCs for Danshen samples.
Figure 12(A) 2D score plot of the two latent variables and (B) VIP plot for Danshen samples based on PLS-DA.